At the news
? NEUTRALIMPACT 2/10 3 filed Jun 23, 2026 at 16:05 ET
Barry Greene filed an initial beneficial ownership statement (Form 3) with the SEC, indicating he has become an officer, director, or 10% shareholder of Dyne Therapeutics. The filing includes a standard limited power of attorney for Section 16 reporting. No transactions or holdings were disclosed.
- Form 3 filed by Barry Greene on June 22, 2026
- Powers of attorney granted for Section 16 filings
- No securities transactions or holdings reported in this filing
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access